Michael Raab sold $223k of ARDX
President & CEO at ARDELYX, INC.. 41,666 shares at an average of $5.36, traded Jan 31, 2025, filed Jan 31, 2025.
Score components
- +25RoleCEO
- +12Trade size$223k at market
- 0Share of holdings soldSold 3.6% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-25-003378, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 31, 2025 | MOption exercise Common Stock10b5-1 | +20,833 | $0.99 | $21k | 1,150,385 | Jan 31, 2025 |
| Jan 31, 2025 | SOpen-market sale Common Stock10b5-1 | -41,666 | $5.36 | $223k | 1,108,719 | Jan 31, 2025 |
| Jan 31, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,833 | $0.00 | $0 | 478,334 | Jan 31, 2025 |
Related signals
Other insiders at ARDELYX, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | ARDELYX, INC. | Mike Kelliher Chief Business Officer | $32k 5,417 shares | -2% | |
| 18Weak | ARDELYX, INC. | Laura A Williams Chief Patient Officer | $490k 80,000 shares | -18% | |
| 39Weak | ARDELYX, INC. | Eric Duane Foster Chief Commercial Officer | $91k 15,308 shares | -5% | |
| 36Weak | ARDELYX, INC. | Elizabeth A Grammer See Remarks | $35k 5,841 shares | -2% | |
| 53Moderate | ARDELYX, INC. | Michael Raab President & CEO | $271k 45,687 shares | -3% | |
| 43Moderate | ARDELYX, INC. | Justin A Renz Chief Financial Officer | $42k 7,037 shares | -2% | |
| 36Weak | ARDELYX, INC. | Laura A Williams Chief Patient Officer | $37k 6,261 shares | -2% | |
| 52Moderate | ARDXbuy ARDELYX, INC. | David M Mott director | $726k 200,000 shares | +7% | |
| 52Moderate | ARDXbuy ARDELYX, INC. | David M Mott director | $737k 200,000 shares | +8% | |
| 30Weak | ARDELYX, INC. | Eric Duane Foster Chief Commercial Officer | $10k 2,507 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.